Prof. Dr. Olaf Müller

MD, MPH
Professor of Public Health

Head of Working Group “Disease Control in Disadvantaged Population Groups”

Olaf Müller is a specialist in Global Health. His research and teaching focus is on principles and strategies of infectious disease control and disease eradication – such as malaria, HIV/AIDS and polio programs.

Olaf has been the principal investigator and co-investigator on grants for large community-based studies from a number of science funders, such as the German Science Foundation, MRC The Gambia, the European Union, the Bill and Melinda Gates Foundation, and the World Health Organization. He has also received research funding from the German Academic Exchange Service, from the Deutsche Gesellschaft für Internationale Gesundheit and from industry.

He has published more than 200 scientific articles and book chapters, including in The New England Journal of Medicine, BMJ, The Lancet, Lancet Infectious Diseases, Lancet Global Health, and PLOS Medicine.

Education

Publications (20 out of 215) 

Müller O, Moser R. HIV-1 disease in a Kampala Hospital. The Lancet (short report) 335: 236-237 (1990)

Müller O, Moser R, Guggenberger P, Alexander M. AIDS in Africa. The New England Journal of Medicine (short report) 12: 847-848 (1991)

Müller O, Barugahare L, Schwartländer B, Byaruhanga E, Kataaha P, Keyyune D, Heckmann W, Ankrah M: HIV prevalence, attitudes and behaviour in clients of a confidential HIV testing and counselling center in Uganda. AIDS, 6: 869-74 (1992)

Müller O, Quinones M, Cham K, Aikins M, Greenwood B. Detecting permethrin on treated bednets. The Lancet (short report), 344: 1699-1700 (1994)

Müller O, Boele van Hensbroek M, Jaffar S, Drakeley C, Okorie C, Joof D, Pinder M, Greenwood B. A randomized trial of chloroquine, amodiaquine, and pyrimethamine-sulfadoxine in Gambian children with uncomplicated malaria. Tropical Medicine & International Health, 1: 124-132 (1996)

Müller O, Sen G, Nsubuga A. HIV/AIDS, orphans, and access to school education in a community of Kampala/Uganda. AIDS, 13:146-147 (1999)

Müller O, Becher H, Baltussen A, Ye Y, Diallo D, Konate M, Gbangou A, Kouyate B, Garenne M. Effect of zinc supplementation on malaria and other causes of morbidity in Westafrican children: randomized double-blind placebo-controlled trial. British Medical Journal, 322: 1567-1572 (2001)

Müller O, Traoré C, Jahn A, Becher H. Severe anaemia in west African children: malaria or malnutrition?. The Lancet (short report) 361: 86-87 (2003)

Müller O, Krawinkel M. Review: Malnutrition and health in developing countries. Journal of the Canadian Medical Association, 173: 279-86 (2005)

Müller O, Traoré C, Kouyaté B, Yé Y, Frey C, Coulibaly B, Becher H. Effects of insecticide-treated bed net protection during early infancy in an African area of intense malaria transmission: randomized controlled trial. Bulletin of the World Health Organisation, 84: 120-26 (2006)

Kouyaté B, Sie A, Yé M, De Allegri M, Müller O. The great failure of malaria control in Africa: a district perspective from Burkina Faso. PLoS medicine 4 (6): e127 (2007)

Müller O, Garenne M, Becher H, Sie A, Kouyate B. Malnutrition, zinc deficiency and malaria in Africa. The Lancet (short report) 369: 2155-56 (2007)

Coulibaly B, Zoungrana A, Mockenhaupt F, Schirmer H, Klose C, Mansmann U, Meissner P, Müller O. Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One 4 (5): e5318 (2009)

Bountogo M, Zoungrana A, Coulibaly B, Klose C, Mansmann U, Mockenhaupt F, Burhenne J, Mikus G, Walter-Sack I, Schirmer RH, Sié A, Meissner P, Müller O. Short communication: Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso. Tropical Medicine & International Health 15: 713-17 (2010)

Louis V, Bals J, Tiendrebéogo J, Bountogo M, Ramroth H, De Allegri M, Traoré C, Beiersmann C, Coulibaly B, Yé M, Jahn A, Becher H, Müller O.. Long-term effects of malaria prevention with insecticide-treated mosquito nets on morbidity and mortality in African children: randomised controlled trial. Tropical Medicine & International Health 17: 733-41 (2012)

Müller O, Mockenhaupt FP, Marks B, Meissner P, Coulibaly B, Kuhnert R, Buchner H, Schirmer RH, Walter-Sack I, Sié A, Mansmann U. Haemolysis risk in methylene blue treatment of G6PD sufficient and G6PD deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs. Pharmacoepidemiology and Drug Safety 22 (4): 376-85 (2013)

Lu G, Zhou S, Horstick O, Wang X, Liu Y, Müller O. Malaria outbreaks in China (1990-2013): A systematic review. Malaria Journal 13: 269 (2014)

Coulibaly B, Pritsch M, Bountogo M, Meissner PE, Nebié E, Klose C, Kieser M, Berens-Riha N, Wieser A, Sirima SB, Breitkreutz J, Schirmer RH, Sié A, Mockenhaupt FP, Drakeley C, Bousema T, Müller O. Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomised controlled trial in Burkina Faso. The Journal of Infectious Diseases 211 (5): 689-97 (2015)

Fisker AB, Nebie E, Schoeps A, Martins C, Rodrigues A, Zakane A, Kagone M, Byberg S, Thysen SM, Tiendrebeogo J, Coulibaly B, Sankoh O, Becher H, Whittle HC, van der Klis FRM, Benn CS, Sié A, Müller O, Aaby P. A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels. Clinical Infectious Diseases 66: 1573-80 (2017)